RecruitingNot ApplicableNCT05660603

Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks in Hip Fracture Surgery

Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks for Sensory Level and Postoperative Analgesia Obtained in Hip Fracture Surgery


Sponsor

Zagazig University

Enrollment

63 participants

Start Date

Dec 20, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Hip fracture (HF) is one of the major worldwide problems that constitute a significant mortality rate, ranging from 14- 36% in the first year after injury, and is associated with profound temporary and sometimes permanent impairment of independence and quality of life in the geriatric population. Surgical treatment is considered the best option for patients with hip fractures,s especially in the elderly, however, it is associated with moderate to severe postoperative pain. Pain is one of the main factors limiting ambulation, increasing the risk of thromboembolism by immobility and causing metabolic changes that affect other systems. Therefore, individualized pain management with the use of appropriate analgesic techniques is of paramount importance. Moreover, early intervention of rehabilitation aiming at a better postoperative recovery may reduce the length of hospital stay and return to daily. Effective pain management is one of the crucial components in enhanced recovery after surgery (ERAS). • Numerous regional anesthetic techniques have been used to provide analgesia following hip fracture surgery, including intrathecal morphine, epidural analgesia, fascia iliaca block, lumber plexus block, and sacral plexus block, however, each of these techniques has specific limitations that prevent them from being the analgesic technique of choice for hip fracture surgery. To our knowledge, there is no study done to compare circum-psoas block versus the combined lumbar and sacral plexus blocks as pre-emptive analgesia in patients undergoing hip fracture surgery under general anesthesia.


Eligibility

Min Age: 60 Years

Inclusion Criteria5

  • Patient acceptance.
  • BMI ≤ 30 kg/m2
  • ASA I-III.
  • First unilateral surgery for hip fracture including femoral neck, intertrochanteric or subtrochanteric fracture.
  • Patient with planned hip fracture surgery within 24-72 hours under general anesthesia.

Exclusion Criteria7

  • Multiple trauma, multiple fractures, or pathological fractures
  • Prosthetic fracture or usage of bone-cement fixation in the surgery.
  • Scheduled for bilateral hip fracture surgery.
  • Pre-existing neurological deficit in the lower extremity
  • Contraindication for peripheral nerve block (infection at the site of needle insertion, coagulopathy, allergy to local anesthetics used)
  • History of chronic pain and taking analgesics
  • History of cognitive dysfunction or mental illness

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcontrol

patients will receive standard general anesthesia

PROCEDURELSP

patients will receive standard general anesthesia followed by ultrasound-guided combined lumbar and sacral plexus blocks with 40 ml of bupivacaine 0.25%.

PROCEDURECP

patients will receive standard general anesthesia followed by ultrasound-guided circum-psoas blocks with 40 ml of bupivacaine 0.25%.

DEVICEUltrasound

ultrasound


Locations(1)

Shereen E Abd Ellatif

Zagazig, Alsharqia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05660603


Related Trials